These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 24628797)

  • 1. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of self-reported cannabis dose and potency: an ecological study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2013 Oct; 108(10):1801-8. PubMed ID: 23627816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.
    Korf DJ; Benschop A; Wouters M
    Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Just say 'know': how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
    Freeman TP; Morgan CJ; Hindocha C; Schafer G; Das RK; Curran HV
    Addiction; 2014 Oct; 109(10):1686-94. PubMed ID: 24894801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on van der Pol et al. (2014): Reconsidering the association between cannabis exposure and dependence.
    Temple EC
    Addiction; 2014 Jul; 109(7):1110-1. PubMed ID: 24903289
    [No Abstract]   [Full Text] [Related]  

  • 8. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model.
    Hunault CC; van Eijkeren JC; Mensinga TT; de Vries I; Leenders ME; Meulenbelt J
    Toxicol Appl Pharmacol; 2010 Aug; 246(3):148-53. PubMed ID: 20450927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study.
    Böcker KB; Gerritsen J; Hunault CC; Kruidenier M; Mensinga TT; Kenemans JL
    Pharmacol Biochem Behav; 2010 Jul; 96(1):67-74. PubMed ID: 20417659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled Δ9-Tetrahydrocannabinol Cannabis Market Products in Occasional and Daily Users.
    Henthorn TK; Wang GS; Dooley G; Brooks-Russell A; Wrobel J; Limbacher S; Kosnett M
    Ther Drug Monit; 2024 Oct; 46(5):672-680. PubMed ID: 39235358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
    Azorlosa JL; Heishman SJ; Stitzer ML; Mahaffey JM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):114-22. PubMed ID: 1313866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health differences between frequent cannabis users with and without dependence and the general population.
    van der Pol P; Liebregts N; de Graaf R; Ten Have M; Korf DJ; van den Brink W; van Laar M
    Addiction; 2013 Aug; 108(8):1459-69. PubMed ID: 23530710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydrocannabinol content and differences in marijuana smoking behavior.
    Herning RI; Hooker WD; Jones RT
    Psychopharmacology (Berl); 1986; 90(2):160-2. PubMed ID: 3024196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
    Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC.
    Van Laar M; Van Der Pol P; Niesink R
    Int J Drug Policy; 2016 Aug; 34():58-64. PubMed ID: 27471078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.